Multiple pathways to tumor immunity and concomitant autoimmunity.
about
New perspectives on the role of vitiligo in immune responses to melanomaAbility of salivary biomarkers in the prognostic of systemic and buccal inflammation.Immunologic functions as prognostic indicators in melanomaBroad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumorsUsing virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma.An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.Primitive immune systems: are your ways my ways?Immunotherapy targets in pediatric cancer.Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells.Interleukin-35 Limits Anti-Tumor Immunity.Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: potential theranostic approach to cancer.Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumorHarnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality?Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma.Immunotherapy in head and neck cancer: current practice and future possibilities.A systematic review of humoral immune responses against tumor antigens.Prevalence of antitumor antibodies in laying hen model of human ovarian cancerAutoimmune thyroid disease elicited by NY-ESO-1 vaccination.Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers.Autoimmunity and tumor immunity induced by immune responses to mutations in self.FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell Carcinoma.Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells.Metastatic Melanoma of Uncertain Primary with 5-Year Durable Response after Conventional Therapy: A Case Report with Literature Review.
P2860
Q26996799-46AA7AC4-BCF3-4E33-8845-9EF0539B67FCQ33676905-CBAC3B2D-079C-4577-B289-2397D16F28A4Q33835011-34793A23-8048-4520-92EE-B93623390B6DQ33936327-1DE71EE2-AC7A-4FD2-AD62-6162C7BE8653Q34198856-EF811960-4D2A-4C5D-B898-0F9A0379A218Q35800650-68668B9B-2953-4563-B293-54A1E15C7433Q35806839-B44C9166-B059-40C2-A66E-17B4E54A1E72Q35971029-68CD2127-9CCA-4D07-B43F-DE3B82C54DCDQ36399686-B566C848-A5F3-409C-85ED-599D685D5957Q36593479-5CC3AD54-8064-4CAF-B8F6-EA4EF9E87DDCQ36871710-2DC1B28C-A009-4580-B365-443F7B1C290CQ36930696-77F7040A-148D-469F-81CA-6ABCBF022E09Q36958358-E81CDF60-2C61-491C-81DC-CC66FC1D43C9Q37014061-38A7DCC7-F6F3-43EA-A7C4-7DF83E508E30Q37257768-FCF233E8-4388-40B5-9B8B-5A3C627E1572Q37435862-9078F388-67E6-47BD-8D8B-AED720763CB1Q37436255-A2801D04-F220-4298-B5B7-E330702FB6B1Q37587971-CC7DEA84-611C-48DE-B0FE-8CBCF0C2F397Q38238438-7F9CAB1D-948B-436B-8302-E07DED69A590Q46917393-1C9A1D87-6AF9-42DD-BEAF-75B196BB881BQ52839874-F98A115E-C9FD-4C2C-895D-773A0BD4E0D2Q55070721-2096F0E5-975A-40D1-94CF-7DCEDAEE1759Q55372822-67014E28-47C6-4DE3-A4A1-BD0173D95C79
P2860
Multiple pathways to tumor immunity and concomitant autoimmunity.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Multiple pathways to tumor immunity and concomitant autoimmunity.
@ast
Multiple pathways to tumor immunity and concomitant autoimmunity.
@en
type
label
Multiple pathways to tumor immunity and concomitant autoimmunity.
@ast
Multiple pathways to tumor immunity and concomitant autoimmunity.
@en
prefLabel
Multiple pathways to tumor immunity and concomitant autoimmunity.
@ast
Multiple pathways to tumor immunity and concomitant autoimmunity.
@en
P2093
P2860
P1476
Multiple pathways to tumor immunity and concomitant autoimmunity.
@en
P2093
Alan N Houghton
Jedd D Wolchok
José A Guevara-Patino
Mary Jo Turk
Stacie M Goldberg
P2860
P304
P356
10.1034/J.1600-065X.2002.18811.X
P577
2002-10-01T00:00:00Z